GlassScriptPhysician profile
Armando Varela
NPI 1679922389
$4,169.93
in general payments reported to CMS, 2019-2025
37 companies · $759 in 2025
The $759 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $593 · 2022: $917 · 2023: $826 · 2024: $1,075 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,660.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $987.37 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Amgen INC. | $389.24 | 2021-2025 | Repatha, Otezla, Evenity |
| Glaxosmithkline, LLC. | $309.03 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $281.16 | 2021-2025 | |
| Pfizer INC. | $247.04 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $231.58 | 2021-2023 | |
| Medtronic, INC. | $169.05 | 2021-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Lilly USA, LLC | $163.65 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $154.20 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $115.73 | 2022-2024 | |
| Abbott Laboratories | $112.06 | 2021-2024 | Proclaim, Freestyle Libre 3, Freestyle Libre 2 |
| Novo Nordisk INC | $106.90 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Nestle Healthcare Nutrition INC. | $94.28 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.27 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $82.07 | 2022 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armando Varela listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.